翻訳と辞書 |
Selexipag
|Section2= |Section3= }} Selexipag (ACT-293987, NS-304; tentative trade name Uptravi) is a drug currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT-333679 (the free carboxylic acid), are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Selexipag」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|